Abstract
In 2016, according to the National Institute of Statistics and Geography the incidence of breast malignancy among the population aged 20 years and over is 14.80 new cases per 100,000 people. In women, it peaks in those of the 60–64 age group (68.05 for every 100,000 women in that age group). Worldwide, it is estimated that each year 1.38 million new cases are detected and there are 458,000 deaths due to this cause, being this type of cancer with higher incidence among women [1]. Depending on the type of cancer detected, the treatment is different. Doctors indicate, however, that when there is surgery or radiation in the procedure, lymph nodes are removed or damaged resulting in the majority of cases the disease is known as lymphedema. Through the studies of the American Cancer Society [2] it can be observed that “lymphedema is produced by surgery, radiation or cancer”. In this work a literature review will be presented in order to focus on the need of considering Human Factors and Usability evaluations during the first stages of the design process for a new artificial ganglion that may help breast cancer survivors with lymphedema to improve their well-being.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Instituto Nacional de Estadística y Geografía (2016) Estadísticas a propósito del día mundial de la lucha contra el cáncer de mama. http://www.inegi.org.mx/saladeprensa/aproposito/2016/mama2016_0.pdf. Accessed 05 June 2017
American Cancer Society (2016) Qué es lo que causa linfedema vinculado con el cáncer. https://www.cancer.org/es/tratamiento/tratamientos-y-efectossecundarios/efectos-secundarios-fisicos/linfedema/que-es-linfedema.html. Accessed 17 July 2017
Organización Mundial de la Salud (2016) Organización Mundial de la Salud. http://www.who.int/disabilities/care/es/
National Cancer Institute (2017) Aspectos generales de las opciones de tratamiento. https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-pdq#section/_52. Accessed 10 June 2017
National Cancer Institute (2017) Efectos Secundarios. https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-pdq#section/_52. Accessed 15 July 2017
American Cancer Institute (2016) Cirugía de ganglios linfáticos para el cáncer de seno. https://www.cancer.org/es/cancer/cancer-de-seno/tratamiento/cirugia-del-cancer-de-seno/cirugia-de-ganglios-linfaticos-para-el-cancer-de-seno.html. Accessed 16 June 2017
Sharples S, Martin J, Lang A, Craven M, O’Neill S, Barnett J (2012) Medical device design in context: a model of user-device interaction and consequences. Displays 33:221–232
Martin JL, Clark DJ, Morgan SP, Crowe JA, Murphy E (2012) A user-centred approach to requirements elicitation in medical device development: a case study from a industry perspective. Appl Ergon 43:184–190
Vincent CJ, Li Y, Blandford A (2014) Integration of human factors and ergonomics during medical device design and development: it’s all about communication. Appl Ergon 45:413–419
Schmettow M, Schnittker R, Schraagen JM (2017) An extended protocol for usability validation of medical devices: research design and reference model. J Biomed Inf 69:99–114
National Cancer Institute (2017) Anatomía de la mama femenina. Se muestran el pezón, la aréola, los ganglios linfáticos, los lóbulos, los lobulillos, los conductos y otras partes de la mama. https://www.cancer.gov/espanol/tipos/seno. Accessed 20 June 2017
National Cancer Institute (2017) El cáncer se disemina en el cuerpo de tres maneras. https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-pdq#section/_24. Accessed 17 June 2017
Hagedorn TJ, Grosse IR, Krishnamurty S (2015) A concept ideation framework for medical device design. J Biomed Inf 55:218–230
Money A, Barnett J, Kuljis J, Craven M, Martin J, Young T (2011) The role of the user within the medical device design and development process: medical device manufacturers’ perspectives. BMC Med Inf Decis Mak 11:1
Shah SGS, Robinson I (2007) Benefits of and barriers to involving users in medical device technology development and evaluation. Health Care 23:131–137
Clarkson P, Buckle P, Coleman R, Stubbs D, Ward J, Jarret J (2004) Design for patient safety: a review of the effectiveness design in the UK health service. J Eng Des 15:123–140
Vincent CJ, Blandford A (2017) How do health service professionals consider human factors when purchasing interactive medical devices? A qualitative interview study. Appl Ergon 59:114–122
Vincent C, Blanford A (2011) Designing for safety and usability: user-centered techniques in medical device design practice. In: Proceedings of the HdES 55th annual meeting. Sage, Las Vegas, pp 793–797
Furniss D, Masci P, Curzon P, Mayer A, Blandford A (2014) 7 Themes for guiding situated ergonomic assessments of medical devices: a case study of an inpatient glucometer. Appl Ergon 45:1667–1668
Organización Mundial de la Salud, Noviembre 2013. http://www.who.int/mediacentre/factsheets/fs384/es/
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Hernandez-Grajeda, P., Rossa-Sierra, A., Durán-Aguilar, G. (2019). Design and Development of a Medical Device (Artificial Ganglion) for Aids in the Treatment of Lymphedema. In: Bagnara, S., Tartaglia, R., Albolino, S., Alexander, T., Fujita, Y. (eds) Proceedings of the 20th Congress of the International Ergonomics Association (IEA 2018). IEA 2018. Advances in Intelligent Systems and Computing, vol 818. Springer, Cham. https://doi.org/10.1007/978-3-319-96098-2_63
Download citation
DOI: https://doi.org/10.1007/978-3-319-96098-2_63
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-96097-5
Online ISBN: 978-3-319-96098-2
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)